Czasopismo Współczesna Onkologia 2015

Review paper

Hormone therapy in combination with radiotherapy in the treatment of prostate cancer: why and in which group of patients?

Tomasz Milecki, Andrzej Antczak, Zbigniew Kwias, Piotr Milecki

Contemp Oncol (Pozn) 2015; 19 (1): 1–5

DOI: https://doi.org/10.5114/wo.2015.50010

Abstract View text

Review paper

Paraneoplastic syndromes in olfactory neuroblastoma

Michał Kunc, Anna Gabrych, Piotr Czapiewski, Krzysztof Sworczak

Contemp Oncol (Pozn) 2015; 19 (1): 6–16

DOI: https://doi.org/10.5114/wo.2015.46283

Abstract View text

Original paper

Relationship between serotonin transporter gene polymorphism and constipation in cancer patients

Weiwei Li, Luli Huang, Weimei Cai, Sue Cao, Yan Yuan, Sheng Lu, Yanzheng Zhao, Ping Lu

Contemp Oncol (Pozn) 2015; 19 (1): 17–21

DOI: https://doi.org/10.5114/wo.2014.41391

Abstract View text

Original paper

EGFR and KRAS mutations in pulmonary pleomorphic carcinoma and their correlation with clinicopathologic features

Xiaoli Jia, Gang Chen

Contemp Oncol (Pozn) 2015; 19 (1): 22–27

DOI: https://doi.org/10.5114/wo.2014.43491

Abstract View text

Original paper

P27 expression in pleomorphic salivary gland adenoma

Bassel Tarakji, Ayesha Umair, Mohammed Alsakran Altamimi, Saleh Nasser Azzeghaiby, Abla Sayed Mahmoud, Shourouk Darwish, Mohammad Zakaria Nassani, Nipun Ashok

Contemp Oncol (Pozn) 2015; 19 (1): 28–31

DOI: https://doi.org/10.5114/wo.2014.45294

Abstract View text

Original paper

Genistein-induced mir-23b expression inhibits the growth of breast cancer cells

Cigir Biray Avci, Sunde Yilmaz Susluer, Hasan Onur Caglar, Tugce Balci, Duygu Aygunes, Yavuz Dodurga, Cumhur Gunduz

Contemp Oncol (Pozn) 2015; 19 (1): 32–35

DOI: https://doi.org/10.5114/wo.2014.44121

Abstract View text

Original paper

Effect of β-sitosterol on the expression of HPV E6 and p53 in cervical carcinoma cells

Dali Cheng, Zhiqiang Guo, Shulan Zhang

Contemp Oncol (Pozn) 2015; 19 (1): 36–42

DOI: https://doi.org/10.5114/wo.2015.50011

Abstract View text

Original paper

The use of Yttrium-90 Ibritumomab Tiuxetan (⁹⁰Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation

Wojciech Jurczak, Elżbieta Kisiel, Joanna Sawczuk-Chabin, Piotr Centkowski, Wanda Knopińska-Posłuszny, Omeir Khan

Contemp Oncol (Pozn) 2015; 19 (1): 43–47

DOI: https://doi.org/10.5114/wo.2015.50012

Abstract View text

Original paper

The prognostic significance of tumor epidermal growth factor receptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma

Igor Richter, Josef Dvořák, Marek Urbanec, Antonin Bluml, Eva Čermáková, Jiří Bartoš, Jiří Petera

Contemp Oncol (Pozn) 2015; 19 (1): 48–53

DOI: https://doi.org/10.5114/wo.2015.50013

Abstract View text

Original paper

Results of surgical management of renal cell carcinoma metastatic to the pancreas

Katarzyna Kusnierz, Slawomir Mrowiec, Pawel Lampe

Contemp Oncol (Pozn) 2015; 19 (1): 54–59

DOI: https://doi.org/10.5114/wo.2014.45306

Abstract View text

Original paper

Preliminary results of tomotherapy for treatment of inoperable recurrent non-small cell lung cancer at bronchial stump site after right pneumonectomy

Hong Seok Jang, Seong Kwon Moon

Contemp Oncol (Pozn) 2015; 19 (1): 60–71

DOI: https://doi.org/10.5114/wo.2015.48179

Abstract View text

Original paper

The risk factors of toxicity during chemotherapy and radiotherapy in breast cancer patients according to the presence of BRCA gene mutation

Joanna Huszno, Magdalena Budryk, Zofia Kołosza, Elżbieta Nowara

Contemp Oncol (Pozn) 2015; 19 (1): 72–76

DOI: https://doi.org/10.5114/wo.2015.50014

Abstract View text

Original paper

Analysis of the influence of parenteral cancer chemotherapy on the health condition of oral mucosa

Mansur Rahnama, Barbara Madej-Czerwonka, Izabela Jastrzębska-Jamrogiewicz, Rafał Jamrogiewicz

Contemp Oncol (Pozn) 2015; 19 (1):77–82

DOI: https://doi.org/10.5114/wo.2014.45291

Abstract View text

Letter to the Editor

Sustained remission after ABVD treatment for interdigitating dendritic cell sarcoma

Grzegorz Helbig, Ryszard Wichary, Jacek Pająk, Maria Budny, Małgorzata Makowska, Klaudyna Machura, Marcin Kubeczko, Sławomira Kyrcz-Krzemień

Contemp Oncol (Pozn) 2015; 19 (1): 83–85

DOI: https://doi.org/10.5114/wo.2014.43974

View text

Hormone therapy in combination with radiotherapy in the treatment of prostate cancer: why and in which group of patients?

Paraneoplastic syndromes in olfactory neuroblastoma

Relationship between serotonin transporter gene polymorphism and constipation in cancer patients

EGFR and KRAS mutations in pulmonary pleomorphic carcinoma and their correlation with clinicopathologic features

P27 expression in pleomorphic salivary gland adenoma

Genistein-induced mir-23b expression inhibits the growth of breast cancer cells

Effect of β-sitosterol on the expression of HPV E6 and p53 in cervical carcinoma cells

The use of Yttrium-90 Ibritumomab Tiuxetan (⁹⁰Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation

The prognostic significance of tumor epidermal growth factor receptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma

Results of surgical management of renal cell carcinoma metastatic to the pancreas

Preliminary results of tomotherapy for treatment of inoperable recurrent non-small cell lung cancer at bronchial stump site after right pneumonectomy

The risk factors of toxicity during chemotherapy and radiotherapy in breast cancer patients according to the presence of BRCA gene mutation

Analysis of the influence of parenteral cancer chemotherapy on the health condition of oral mucosa

Sustained remission after ABVD treatment for interdigitating dendritic cell sarcoma

Coverage in

Indexed in

Integrated with

Editorial Policies

Hormone therapy in combination with radiotherapy in the treatment of prostate cancer: why and in which group of patients?

Paraneoplastic syndromes in olfactory neuroblastoma

Relationship between serotonin transporter gene polymorphism and constipation in cancer patients

EGFR and KRAS mutations in pulmonary pleomorphic carcinoma and their correlation with clinicopathologic features

P27 expression in pleomorphic salivary gland adenoma

Genistein-induced mir-23b expression inhibits the growth of breast cancer cells

Effect of β-sitosterol on the expression of HPV E6 and p53 in cervical carcinoma cells

The use of Yttrium-90 Ibritumomab Tiuxetan (90Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation

The prognostic significance of tumor epidermal growth factor receptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma

Results of surgical management of renal cell carcinoma metastatic to the pancreas

Preliminary results of tomotherapy for treatment of inoperable recurrent non-small cell lung cancer at bronchial stump site after right pneumonectomy

The risk factors of toxicity during chemotherapy and radiotherapy in breast cancer patients according to the presence of BRCA gene mutation

Analysis of the influence of parenteral cancer chemotherapy on the health condition of oral mucosa

Sustained remission after ABVD treatment for interdigitating dendritic cell sarcoma

Coverage in

Indexed in

Integrated with

Editorial Policies

The use of Yttrium-90 Ibritumomab Tiuxetan (⁹⁰Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation